BDebate: Synthetic Biology. Engineering life for the medicine of the future

This conference on synthetic biology is focused on medical applications on gene editing technologies. Our capacity to engineer genomes has increased enormously, and this advancement is impacting science and society. Synthetic Biology drives to a new era in a wide variety of research fields ranging from sustainable energy, food production, biomaterials, better understanding human biology, and development of novel therapies. Engineering of life is changing the medicine of the future.

We will create a forum to foster discussion between top scientists but also engage industry and society, to promote scientific advancement and its sustainable translation into economic and health benefits for society. 

Confirmed speakers: 

• Sarah Chan, The University of Edinburgh, UK
• Laia Crespo, Sanofi Ventures, ES
• Victor de Lorenzo, Spanish National Centre for Biotechnology, ES
• Luis Ángel Fernández, Spanish National Centre for Biotechnology, ES
• Jordi Garcia-Ojalvo, Pompeu Fabra University, ES
• Manel Juan Otero, Hospital Clínic de Barcelona, ES
• Carole Lartigue, French National Institute for Agricultural Research, FR
• Maria Lluch-Senar, Centre for Genomic Regulation, ES
• Prashant Mali, UC San Diego, US
• Lluís Montoliu, Spanish National Centre for Biotechnology, ES
• Julia Oh, The Jackson Laboratory, US
• Matthew Porteus, Stanford Medicine, US
• Francesc Posas, Pompeu Fabra University, ES
• Sylvain Sachot, Asabys Partners, Barcelona, ES
• José Carlos Segovia, Centre for Energy, Environment and Technology Research (CIEMAT), ES
• Luhan Yang, eGenesis Bio, US

Event webpage: https://www.bdebate.org/ca/debat/impact-synthetic-biology-future-medicine